Danimer Scientific, Inc.
DNMR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,839 | -$22,661 | -$27,263 | -$39,434 |
| Dep. & Amort. | $7,335 | $7,438 | $10,349 | $7,372 |
| Deferred Tax | $0 | $0 | $0 | -$27,790 |
| Stock-Based Comp. | $524 | $595 | $966 | $13,808 |
| Change in WC | -$372 | -$2,312 | $2,684 | -$986 |
| Other Non-Cash | -$147 | -$2,030 | $273 | $64,393 |
| Operating Cash Flow | -$14,499 | -$18,970 | -$12,991 | $17,363 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,716 | -$1,800 | -$1,970 | -$1,963 |
| Net Acquisitions | $0 | $0 | $0 | $4 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1,167 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,549 | -$1,800 | -$1,970 | -$1,959 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$977 | $3,610 | -$606 | -$593 |
| Stock Issued | -$141 | $8 | $4,650 | $225 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $48 | -$7 | $8,993 | -$33,386 |
| Financing Cash Flow | -$1,070 | $3,611 | $13,037 | -$33,754 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18,118 | -$17,159 | -$1,924 | -$18,350 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $54,421 | $71,580 | $59,170 | $77,393 |
| End Cash | $36,303 | $54,421 | $57,341 | $59,170 |
| Free Cash Flow | -$18,215 | -$20,770 | -$14,961 | $15,400 |